SCHEMBL289762

SCHEMBL289762

Cc1ccc2sc(B(O)O)cc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.58
CYP2A6 P11509 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2945825 0.85 MGLL (0.58) MGLLCYP2A6
SCHEMBL29952719 0.85 MGLL (0.58) MGLLCYP2A6
SCHEMBL29954520 0.78 MGLL (0.60) MGLL
SCHEMBL14405961 0.78 MGLL (0.60) MGLL
SCHEMBL290043 0.77 MGLL (0.58) MGLL
SCHEMBL2205839 0.77 MGLL (0.58) MGLL
SCHEMBL29956374 0.77 MGLL (0.58) MGLL
SCHEMBL1901107 0.77 MGLL (0.58) MGLL
SCHEMBL25235116 0.77 MGLL (0.53) MGLL
SCHEMBL15191909 0.77 MGLL (0.53) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12479865-B2 Organic compound, organic photoelectric device, image sensor, and electronic device SAMSUNG ELECTRONICS CO., LTD. (KR) 2025-11-25 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
WO-2022166469-A1 FGFR KINASE INHIBITOR AND USE THEREOF 药雅科技(上海)有限公司 2022-08-11 WO disclosed
US-20220153745-A1 DISUBSTITUTED BENZOTHIENYL-PYRROLOTRIAZINES AND THEIR USE AS FGFR KINASE INHIBITORS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2022-05-19 US disclosed
US-20220041628-A1 ORGANIC COMPOUND, ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-02-10 US disclosed
US-20220041628-A1 ORGANIC COMPOUND, ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-02-10 US disclosed
US-20190016724-A1 DISUBSTITUTED BENZOTHIENYL-PYRROLOTRIAZINES AND THEIR USE AS FGFR KINASE INHIBITORS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2019-01-17 US disclosed
US-9988378-B2 1 H-pyrazole and 4,5-disubstituted thiazole inhibitors of SYK HOFFMANN-LA ROCHE INC. (CH) 2018-06-05 US disclosed
EP-2993169-B1 ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS NOVARTIS AG (CH) 2017-12-20 EP disclosed
US-9598416-B2 Substituted benzothienyl-pyrrolotriazines and uses thereof in the treatment cancer BAYER INTELLECTUAL PROPERTY GMBH (DE) 2017-03-21 US disclosed
WO-2010128163-A2 SMALL MOLECULE INHIBITORS OF INFLUENZA A AND B VIRUS AND RESPIRATORY SYNCYTIAL VIRUS REPLICATION PIKE PHARMA GMBH (CH) 2010-11-11 WO disclosed
WO-2009049028-A1 PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USE AS JANUS KINASE MODULATORS TARGEGEN INC. (US) 2009-04-16 WO disclosed
WO-2009046416-A1 ANILINOPYRIMIDINES AS JAK KINASE INHIBITORS TARGEGEN INC. (US) 2009-04-09 WO disclosed
US-20080076924-A1 Piperazines as P2X7 antagonists ABBOTT LABORATORIES 2008-03-27 US disclosed
US-20080076924-A1 Piperazines as P2X7 antagonists ABBOTT LABORATORIES 2008-03-27 US disclosed
US-20070282101-A1 Indazole compounds ABBVIE INC. 2007-12-06 US disclosed
EP-0863755-B1 ANTITHROMBOTIC DIAMINES LILLY CO ELI (US) 2004-12-15 EP disclosed
US-6265575-B1 THROMBIN INHIBITORS ELI LILLY AND COMPANY 2001-07-24 US disclosed
US-6251921-B1 ADMINISTERING THROMBIN INHIBITING DIAMINE COMPOUND TO MAMMAL ELI LILLY AND COMPANY 2001-06-26 US disclosed
US-6025382-A Antithrombotic diamines ELI LILLY AND COMPANY (US) 2000-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153745-A1 DISUBSTITUTED BENZOTHIENYL-PYRROLOTRIAZINES AND THEIR USE AS FGFR KINASE INHIBITORS NR5A2, FGFR1, FGFR3 MGLL 4861/4885CYP2A6 955/4885
US-20070282101-A1 Indazole compounds CYP3A43, CYP3A7, UGT1A1 MGLL 3633/4885CYP2A6 75/4885
US-12479865-B2 Organic compound, organic photoelectric device, image sensor, and electronic device OR10J3, OR51E2, ORC3 MGLL 3807/4885CYP2A6 728/4885
US-20190016724-A1 DISUBSTITUTED BENZOTHIENYL-PYRROLOTRIAZINES AND THEIR USE AS FGFR KINASE INHIBITORS FGFR1, NR5A2, FGFR3 MGLL 4837/4885CYP2A6 919/4885
US-20220041628-A1 ORGANIC COMPOUND, ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE OR10J3, OR51E2, ORC3 MGLL 3807/4885CYP2A6 728/4885
US-20080076924-A1 Piperazines as P2X7 antagonists P2RX7, P2RX1, P2RX2 MGLL 4241/4885CYP2A6 1106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.